Even people which have never smoked can develop lung cancer. In this population a mutation in the exons 19-21 of the Epidermal Growth Factor Receptor (EGFR) can be detected. For this patient group targeted therapies with EGFR tyrosinkinase inhibitors are available. In this case report we describe a 37 year old non-smoker who developed a non-small cell lung cancer. Following therapy with Erlotinib a partial response could be achieved.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00108-008-2239-0DOI Listing

Publication Analysis

Top Keywords

lung cancer
8
[hemorrhagic pericardial
4
pericardial effusion
4
effusion multiple
4
multiple pulmonary
4
pulmonary nodules
4
nodules year
4
year male
4
male "never
4
"never smoked"]
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!